Early-stage medtech development is a high-stakes balancing act between technical innovation and regulatory rigor. At Ontogen Medtech, we specialize in the "messy middle"—the critical phase where a brilliant idea must be transformed into a de-risked, manufacturable, and regulatory-ready medical device. We don't just build prototypes; we build the technical and quality foundation your company needs to secure its next round of funding and clear the path to FDA submission.
Don't Just Build a Prototype.
Build a Pathway.
Regulatory Strategy & Advising
Regulatory hurdles should never be a surprise. We bake compliance into the development process from day one, ensuring your technical milestones align with your commercial goals.
A well-crafted regulatory strategy is essential for guiding the development pathway of a medical device. By identifying the correct product code and FDA device classification early on, developers can align their technical milestones with regulatory requirements, ensuring a smoother approval process. This strategic alignment helps in anticipating potential regulatory hurdles and integrating compliance into the development plan from the outset, ultimately reducing time to market and avoiding costly delays.
Complete all necessary forms, compile the data meticulously, and conduct thorough gap assessments to ensure no detail is overlooked. Once prepared, submit the comprehensive package to the FDA, ensuring that all regulatory requirements are met and potential issues are preemptively addressed. This involves a detailed review of predicate devices, ensuring substantial equivalence, and preparing a robust summary of safety and effectiveness data. Our team will guide you through each step, from initial planning to final submission, ensuring a seamless process.
The path to Class III device approval is intricate, demanding careful planning and execution. Our proficiency in the IDE process ensures that your submissions meet FDA standards. We assist in protocol development, regulatory submissions, and ongoing FDA interactions, helping to mitigate risks and streamline your path to market.
When no existing product code fits your new device, our team will spearhead the interaction with the FDA to request a new classification. This proactive approach ensures your device is properly categorized, facilitating a more efficient approval process.
Our team excels in facilitating Q-sub meetings, which are crucial for aligning with the FDA on device classification, compliance requirements, and testing strategies. These meetings provide an opportunity to clarify expectations and address any potential concerns early in the development process, ensuring a smoother path to approval.
Securing a Breakthrough Device designation from the FDA can be a game-changer for your product, offering a streamlined regulatory pathway and enhanced interaction with the FDA. This designation is reserved for devices that promise significant advancements in treatment or diagnosis. Our expertise ensures that your application is robust, meeting all necessary criteria to leverage this opportunity for faster market entry.
Product Strategy & Feasibility
Before you scale, you must prove that your technology is both viable and valuable. We help you navigate the ambiguity of early development by anchoring your innovation in user needs and technical reality.
Proof-of-Concept Prototyping
Early feasibility work should answer the biggest technical questions before a team commits to full development. We build proof-of-concept prototypes to evaluate core functions, mechanisms, and workflows quickly and practically. These prototypes are meant to generate learning, expose constraints, and clarify what is worth developing further. The goal is to reduce uncertainty before major time and money are invested.
User Needs & Requirements
Strong device programs begin with a clear understanding of the user, the use environment, and the problem the product must solve. We help translate early concepts into defined user needs, product requirements, and development priorities that can guide engineering. This creates alignment before design work gains momentum and helps prevent costly assumptions from getting baked into the product. The result is a more disciplined, credible starting point for development.
Product Architecture & Development Planning
Early-stage teams often need help deciding what the product is, what it is not, and what must be proven first. We help shape the product definition, identify key risks, and build a practical development plan around the highest-priority unknowns. That includes sequencing work in a way that supports smarter spending, clearer milestones, and better decision-making. Instead of jumping too quickly into full design, you get a more focused path toward an investable and executable program.
Device Design & Engineering
We translate complex concepts into robust, engineered solutions. Our team bridges the gap between a "works-like" prototype and a device that is ready for verification and scalable manufacturing.
Industrial Design
IP Development
Mechanical Engineering
.webp)
Electrical Engineering
.webp)
Firmware / Embedded Systems
Systems Engineering
Design History File (DHF) & FDA Readiness
Our approach integrates robust design control processes and meticulous documentation from the outset, enhancing your device's path through regulatory approvals and FDA audits. With our expertise, we guide you through every step of this intricate journey of FDA compliance, focusing on creating a device that is not only safe and effective but also perfectly aligned with its intended use.
The Design History File (DHF) contains all Design Controls, including Requirements, Design Inputs, Design Outputs, Risk Management and Usability. We offer DHF creation or remediation services to set your product development on the right path for approval.
Every successful medical device starts with well defined marketing and product requirements. User needs are the specific requirements that undergo Design Validation.
We perform all the necessary risk management activities to comply with ISO 14971, including Risk Assessment, Hazard Analysis, Failure Mode Effect Analyses (FMEAs), and risk mitigation and testing.
We ensure your device undergoes the proper user evaluations to comply with IEC 62366. Formative and summative usability evaluations formally document the interaction and feedback from your device users for FDA review.
It’s not enough to simply write the code for your device. Software development for medical devices that follows IEC 62304 ensures that your software output will withstand scrutiny from FDA and other regulatory bodies.
Product design does not end with the device itself. Every medical device requires labeling that complies with the appropriate standards and FDA guidance. Whether durable or disposable labeling, instructions for use, Unique Device Identification (UDI)— we ensure your product labeling is clear, complete, and compliant.
We will develop a solid design verification strategy that includes testing and analysis. We ensure product undergoes testing considering worst-case conditions and with statistically valid sample sizes.
Design Validation Testing is a critical step in ensuring that your medical device meets user needs and performs as intended in real-world scenarios. Our service provides comprehensive testing protocols that simulate actual use conditions, verifying that your product is safe, effective, and ready for market entry.
Our team has extensive experience designing products and developing the documentation to support those products to comply with the appropriate standards which pertain to medical devices.
We have a track record of success demonstrating compliance to applicable medical device standards, such as:
ISO 13485 - Medical devices — Quality management systems
ISO 14971 - Medical devices — Application of risk management to medical devices
ISO 10993 - Biological evaluation of medical devices
ISO 10555 - Intravascular Catheters
IEC 60601-1 - Medical electrical equipment
ISO 14708 - Implants for surgery — Active implantable medical devices
.svg)
.svg)
© 2026 Ontogen Medtech